"In addition to Enerji’s cash balance of $355,000 at the end of the quarter, as announced on 10 April 2015 the Company’s anticipated R&D Rebate of $2.1 million or the 2014 financial year and additional R&D Rebate of $262,000 or the 2013 financial year are expected to be received during the current quarter ending 30 June 2015" In addition to.............
fine then you don't hold and don't want to hold so why post????????
- Forums
- ASX - By Stock
- HYD
- Not worth waiting?
Not worth waiting?, page-28
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add HYD (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.796M |
Open | High | Low | Value | Volume |
1.1¢ | 1.1¢ | 1.1¢ | $1.265K | 115.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 700099 | 1.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.1¢ | 509894 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 700099 | 0.010 |
1 | 100000 | 0.009 |
2 | 190682 | 0.008 |
1 | 200000 | 0.007 |
1 | 300000 | 0.006 |
Price($) | Vol. | No. |
---|---|---|
0.011 | 509894 | 3 |
0.012 | 167832 | 2 |
0.013 | 17679 | 1 |
0.014 | 72810 | 1 |
0.015 | 259228 | 3 |
Last trade - 15.16pm 12/11/2024 (20 minute delay) ? |
Featured News
HYD (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online